Previous 10 | Next 10 |
Cassava Sciences ( NASDAQ: SAVA ) is having its best day in months as shares are up 39% in Wednesday morning trading. Shares got a boost after Tuesday's closing bell when an SEC filing revealed that a company director s ignificantly added to his holding . Even ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Roman Tiraspolsky / Shutterstock.com Blue Apron (NYSE: APRN ) stock is rising on Wednesday as investors weigh the shares’ potential as a short squeeze. Blue Apron has been seeing quite a bit of ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Darryl Brooks / Shutterstock.com ZIM Integrated Shipping (NYSE: ZIM ) stock is falling on Wednesday following the release of its earnings report for the second quarter of 2022 . The first bit of bad n...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Literator / Shutterstock.com Hyzon Motors (NASDAQ: HYZN ) stock is falling on Wednesday after the hydrogen fuel cell vehicle company said it won’t be able to file its earnings report on time . ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) rose 20% in overnight trading after board member Sanford Robertson bought 100,000 shares . Chief financial officer Eric Schoen also bought shares . Before the purchases, SAVA st...
Gainers: Blue Water Vaccines ( BWV ) +57% . Eargo ( EAR ) +49% . Cassava Sciences ( SAVA ) +29% . MiNK Therapeutics ( INKT ) +24% . Cogent Biosciences ( COGT ) +16% . Losers: Blueprint Medicines ( BPMC ) -22% ....
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: 50 Or 75?
Cassava Sciences is up 22% in after-hours trading following the disclosure of a large stock purchase from a member of its board of directors. Director Sanford Robertson, principal of technology buyout fund Francisco Partners, bought 100K shares at $20.69 each on August 12....
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Cassava Sciences, Inc. (NasdaqCM: SAVA). On August 24, 2021, it was disclosed that ...
After at least one year, 50 participants on simufilam experienced a 3.2 point improvement in ADAS-Cog scores whereas another group of 50 participants saw a .2 decline (on average). Acetylcholinesterase inhibitors produce a result between these two points in most individuals after one ...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...